Company / CapEx per Share
Janux Therapeutics, Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.01 / $0.16
FY2021-FY2025
Trend
+152.0%
vs FY2024
Sector context
#107 of 190
Health Care
What the data says
At $0.02, Janux Therapeutics, Inc.'s capex per share ranks #107 of 190 in the Health Care sector. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.02.
Based on SEC 10-K filings.
0.02 in FY2025 with a 3-year CAGR of -52.3%.
Declined from $0.04 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -52.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 190 in Health CareTop 56% of 190This company $0.02 Sector average $2.49
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 152.0% year-over-year.
- Ranks #107 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +152.0% |
| FY2024 | $0.01 | -84.1% |
| FY2023 | $0.04 | -73.0% |
| FY2022 | $0.16 | +146.8% |
| FY2021 | $0.06 | - |
| FY2020 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026